[(Chemo-) prevention of second tumors in patients with head and neck neoplasms].
This review discusses the possible role of chemoprevention in the improvement of survival rates and the prevention of secondary primary tumours in patients with head and neck cancer. Chemoprevention is a new treatment that is especially promising for high risk groups. The fear that the advantages of this treatment will be outweighed by the disadvantages of side-effects and toxicity has not been confirmed by current studies. Randomized studies are needed to show whether chemoprevention can reduce the frequency of second primary tumours.
Universitäts-HNO-Klinik Amsterdam.
N
N
de Vries
H
H
Maier
G B
GB
Snow
D002338:Carotenoids / Q000008:administration & dosage*; D006258:Head and Neck Neoplasms / Q000517:prevention & control*; D006801:Humans; D009378:Neoplasms, Multiple Primary / Q000517:prevention & control*; D012176:Retinoids / Q000008:administration & dosage*; D012307:Risk Factors
D012176:Retinoids; D002338:Carotenoids
(Chemo-)Prävention von Zweittumoren bei Patienten mit Kopf-Hals-Malignomen.